Potassium Chloride Tablet, Film Coated, Extended Release
Product Images NDC 72888-075

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 72888-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Potassium Chloride Extended-release Tablets,usp 1500mg (NDC 72888-076-01)

Potassium Chloride Extended-release Tablets,usp 1500mg (NDC 72888-076-01)
Each tablet contains 1500 mg potassium chloride (equivalent to 20 mEq). The tablets should be stored at room temperature between 20°-25°C (68°-77°F), with limited excursions permitted to extended-release 15°-30°C (59°-86°F). Dispense in a USP tight container and do not accept if seal over the bottle opening is broken or missing. The package insert should be referred to for full prescribing information. This is an FDA-approved assay test sample. Advagen Pharma Limited distributes the 100 tablets, and they are manufactured by Rubicon Research Private Limited in Ambernath, India, with Mfg Lic No. : KD-682.*
FDA Label Image

Potassium Chloride Extended-release Tablets,usp 1500mg (NDC 72888-076-05)

FDA Label Image

Potassium Chloride Extended-release Tablets,usp 750mg (NDC 72888-075-00)

FDA Label Image

Potassium Chloride Extended-release Tablets,usp 750mg (NDC 72888-075-01)

Potassium Chloride Extended-release Tablets,usp 750mg (NDC 72888-075-01)
Each tablet contains 750 mg of potassium chloride. It is recommended to store the medication in a USP tight container at room temperature, between 20°C and 25°C (68°F and 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). The medication should not be accepted if the seal over the bottle opening is broken or missing. The package insert provides full prescribing information. The medication is FDA approved, and the assay test sample preparation differs from USP. The NDC number is 72888-075-01. It is an extended-release tablet intended for prescription only. The medication is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The overprinting area is 50 mm X 15 mm.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.